metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Determinación de la elastasa-1 fecal en el diagnóstico de la pancreatitis cró...
Journal Information
Vol. 25. Issue 6.
Pages 377-382 (January 2002)
Share
Share
Download PDF
More article options
Vol. 25. Issue 6.
Pages 377-382 (January 2002)
Full text access
Determinación de la elastasa-1 fecal en el diagnóstico de la pancreatitis crónica
Fecal Elastase-1 Determination In The Diagnosis Of Chronic Pancreatitis
Visits
68744
J. Martínez
Corresponding author
jmsempere@coma.es

Correspondencia: Dr. J. Martínez Sempere. Sección de Gastroenterología. Hospital General Universitario de Alicante. Pintor Baeza, s/n. 03010 Alicante.
, R. Laveda, C. Trigo, J. Frasquet, J.M. Palazón, M. Pérez-Mateo
Sección de Gastroenterología. Servicio de Medicina Interna. Servicio de Laboratorio. Hospital General Universitario de Alicante. Alicante
This item has received
Article information
Introducciñn

El diagnóstico de pancreatitis crónica se basa en datos morfológicos y funcionales. Para la evaluación de la función excocrina, el test de secretina-colecistocinina constituye el patrón oro, pero resulta invasivo y se encuentra poco disponible. Recientemente, se ha investigado la posibilidad de que la determinación de la elastasa-1 fecal sea un test indirecto de la función pancreática.

Objetivo

Evaluar el valor diagnóstico de la elastasa-1 fecal en la pancreatitis crónica, comparándola con otros métodos indirectos de función pancreática, como el test de pancreolauril en orina y la determinación de quimotripsina fecal. Para ello, analizamos los 3 métodos diagnósticos en 4 grupos de pacientes: grupo I (14 enfermos con pancreatitis crónica confirmada); grupo II (5 pacientes con episodios recurrentes de pancreatitis aguda etílica); grupo III (9 casos con diarrea de origen no pancreático); grupo IV (8 pacientes con otras enfermedades gastrointestinales).

Resultados

Con respecto a los grupos control (grupos III y IV), los pacientes del grupo I y II presentaron concentraciones inferiores de elastasa-1 fecal (grupos I-II: 88 µg/g; grupos III-IV: 635 µg/g; p < 0,0001), quimotripsina fecal (4,3 y 29,3 U/g, respectivamente; p < 0,0001), y pancreolauril (14 y 54%; respectivamente; p < 0,001). La sensibilidad para el diagnostico de pancreatitis cronica confirmada (grupo I) fue del 85,6% para la elastasa-1 fecal y el test de pancreolauril, y del 78,5% para la quimotripsina fecal. Sin embargo, para el grupo II, el test mas sensible fue el pancreolauril (80 frente a 60% para la quimotripsina y solamente 40% para la elastasa-1 fecal). Por otra parte, la elastasa-1 fecal alcanzo la mayor especificidad (94,1 frente a 88,2% para la quimotripsina fecal y 81,3% para el pancreolauril).

Conclusión

La determinación de la elastasa-1 fecal es un método indirecto eficaz en el diagnóstico de pacientes con pancreatitis crónica avanzada. Sin embargo, no mejora la sensibilidad de otros métodos indirectos en estadios iniciales de dicha enfermedad. Su mayor ventaja es su elevada especificidad.

The diagnosis of chronic pancreatitis is based on morphological and functional data. To evaluate exocrine function, the secretin-cholecystokinin test is the gold standard but this is invasive and frequently unavailable. Recently, fecal elastase- 1 determination has been investigated as an indirect test of pancreatic function.

Objective

To evaluate the diagnostic value of fecal elastase- 1 in chronic pancreatitis by comparing it with other indirect methods of evaluating pancreatic function such as the urine pancreolauryl test and fecal chymotrypsin determination. To do this, we analyzed the three diagnostic methods in four groups of patients: group I (14 patients with confirmed chronic pancreatitis); group II (5 patients with recurrent episodes of acute alcoholic pancreatitis; group III (9 patients with non-pancreatic diarrhea); group IV (8 patients with other gastrointestinal diseases).

Results

Compared with the control groups (groups III and IV), patients in groups I and II presented lower levels of fecal elastase-1 (groups I-II: 88 mcg/g, groups III-IV: 635 mcg/g, p < 0.0001), fecal chymotrypsin (4.3 U/g and 29.3 U/g, respectively, p < 0.0001), and pancreolauryl (14% and 54%, respectively, p < 0,001). In the diagnosis of confirmed chronic pancreatitis (group I) the fecal elastase-1 and pancreolauryl tests showed a sensitivity of 85.6% and 78.5%, respectively. However, in group II, the most sensitive test was the pancreolauryl test (80% versus 60% for the chymotrypsin test and only 40% for the fecal elastase-1 test). In contrast, the fecal elastase-1 test showed the highest specificity (94.1% versus 88.2% for the fecal chymotrypsin test and 81.3% for the pancreolauryl test).

Conclusion

Fecal elastase-1 determination is an effective indirect method in the diagnosis of patients with advanced chronic pancreatitis. However, when the disease is in the early stages, its sensitivity is no greater than that of other indirect tests. The greatest advantage of this test is its high specificity.

Full text is only aviable in PDF
Bibliografía
[1.]
P.G. Lankisch, F. Seidensticker, J. Otto, H. Lubbers, R. Mahlke, F. Stockmann, et al.
Secretin-pancreozymin test (SPT) and endoscopic retrograde cholangiopancreatography (ERCP): both are necessary for diagnosing or excluding chronic pancreatitis.
Pancreas, 12 (1996), pp. 149-152
[2.]
L. Gullo.
Value and clinical role of intubation tests in chronic pancreatitis.
Chronic pancreatitis, pp. 287-290
[3.]
J.E. Domínguez-Muñoz, P. Malfertheiner.
Diagnóstico y estadiaje de la pancreatitis crónica (II). El papel de los tests funcionales.
Rev Esp Enferm Digest, 83 (1993), pp. 453-457
[4.]
P. Malfertheiner, M. Buchler, A. Muller, H. Ditschuneit.
Influence of extrapancreatic digestive disorders on the indirect pancreatic function test with fluorescein dilaurate.
Clin Physiol Biochem, 3 (1985), pp. 166-173
[5.]
C. Niederau, J.H. Grendell.
Diagnosis of chronic pancreatitis.
Gastroenterology, 88 (1985), pp. 1973-1995
[6.]
A. Sziegoleit, D. Linder.
Studies on the sterol-binding capacity of human pancreatic elastase 1.
Gastroenterology, 100 (1991), pp. 768-774
[7.]
A. Sziegoleit, E. Krause, H.U. Klor, L. Kanacher, D. Linder.
Elastase 1 and chymotrypsin B in pancreatic juice and feces.
Clin Biochem, 22 (1989), pp. 85-89
[8.]
P.G. Lankisch, A. Schreiber, J. Otto.
Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function.
Dig Dis Sci, 28 (1983), pp. 490-493
[9.]
J.E. Domínguez-Muñoz, O. Pieramico, M. Buchler, P. Malfertheiner.
Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis.
Am J Gastroenterol, 88 (1993), pp. 1237-1241
[10.]
H.K. Durr, M. Otte, M.M. Forell, J.C. Bode.
Fecal chymotroypsin: a study on its diagnostic value by comparison with the secretincholecystokinin test.
Digestion, 17 (1978), pp. 404-409
[11.]
C. Loser, A. Mollgaard, U.R. Folsch.
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Gut, 39 (1996), pp. 580-586
[12.]
J. Stein, M. Jung, A. Sziegoleit, S. Zeuzem, W.F. Caspary, B. Lembcke.
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function.
Clin Chem, 42 (1996), pp. 222-226
[13.]
A. Leodolter, G. Denapiene, S. Kahl, C. Gerards, B. Glasbrenner, P. Malfertheiner.
Are repeated determinations of fecal elastase more accurate for diagnosis of exocrine pancreatic insufficiency in patients with chronic pancreatitis?.
Digestion, 61 (2001), pp. 298
[14.]
A. Carroccio, G. Iacono, S. Ippolito, F. Verghi, F. Cavataio, M. Soresi, et al.
Usefulness of faecal elastase-1 assay in monitoring pancreatic function in childhood coeliac disease.
Ital J Gastroenterol Hepatol, 30 (1998), pp. 500-504
[15.]
J. Walkowiak, W.K. Cichy, K.H. Herzig.
Comparison of fecal elastase-1 determination with the secretin- cholecystokinin test in patients with cystic fibrosis.
Scand J Gastroenterol, 34 (1999), pp. 202-207
[16.]
A. Carroccio, F. Verghi, B. Santini, V. Lucidi, G. Iacono, F. Cavataio, et al.
Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.
Dig Dis Sci, 46 (2001), pp. 1335-1342
[17.]
G. Masoero, C. Zaffino, C. Laudi, L. Lombardo, R. Rocca, L. Gallo, et al.
Fecal pancreatic elastase 1 in the work up of patients with chronic diarrhea.
Int J Pancreatol, 28 (2000), pp. 175-179
[18.]
J.E. Domínguez-Muñoz, C. Hieronymus, T. Sauerbruch, P. Malfertheiner.
Fecal elastase test: evaluation of a new noninvasive pancreatic function test.
Am J Gastroenterol, 90 (1995), pp. 1834-1837
[19.]
S.T. Amann, M. Bishop, C. Curington, P.P. Toskes.
Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis.
Pancreas, 13 (1996), pp. 226-230
[20.]
B. Glasbrenner, A. Schon, S. Klatt, K. Beckh, G. Adler.
Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis.
Eur J Gastroenterol Hepatol, 8 (1996), pp. 1117-1120
[21.]
J. Stein, D. Schoonbroodt, M. Jung, B. Lembcke, W.F. Caspary.
Measure de l'elastase 1 fécale par immunoréactivité: une nouvelle approche indirecte de la fonction pancréatique.
Gastroenterol Clin Biol, 20 (1996), pp. 424-429
[22.]
M. Katschinski, J. Schirra, A. Bross, B. Goke, R. Arnold.
Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis.
Pancreas, 15 (1997), pp. 191-200
[23.]
P.G. Lankisch, I. Schmidt, H. Konig, D. Lehnick, R. Knollmann, M. Lohr, et al.
Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency.
Gut, 42 (1998), pp. 551-554
[24.]
L. Gullo, M. Ventrucci, P. Tomassetti, M. Migliori, R. Pezzilli.
Fecal elastase 1 determination in chronic pancreatitis.
Dig Dis Sci, 44 (1999), pp. 210-213
[25.]
A. Leodolter, S. Kahl, J.E. Domínguez-Muñoz, C. Gerards, B. Glasbrenner, P. Malfertheiner.
Comparison of two tubeless function tests in the assessment of mild-to- moderate exocrine pancreatic insufficiency.
Eur J Gastroenterol Hepatol, 12 (2000), pp. 1335-1338
[26.]
R.W. Ammann, B. Muellhaupt.
Progression of alcoholic acute to chronic pancreatitis.
Gut, 35 (1994), pp. 552-556
[27.]
J.E. Domínguez-Muñoz, P. Malfertheiner.
Optimized serum pancreolauryl test for differentiating patients with and without chronic pancreatitis.
Clin Chem, 44 (1998), pp. 869-875
[28.]
B. Fischer, S. Hoh, M. Wehler, E.G. Hahn, H.T. Schneider.
Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea.
Scand J Gastroenterol, 36 (2001), pp. 771-774
[29.]
J. Sáez, J. Martínez, P. Griñó, C. García, M. Pérez-Mateo.
Idiopathic pancreatitis associated with ulcerative colitis.
Am J Gastroenterol, 95 (2000), pp. 3004-3005
[30.]
K. Yoshida, F. Toki, T. Takeuchi, S. Watanabe, K. Shiratori, N. Hayashi.
Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.
Dig Dis Sci, 40 (1995), pp. 1561-1568
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos